Picture of Akoya Biosciences logo

AKYA Akoya Biosciences Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Annual cashflow statement for Akoya Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinal
Net Income/Starting Line-14.8-16.7-42.9-70.6
Depreciation
Deferred Taxes
Non-Cash Items-0.8593.656.797.8
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1.382.39-4.562.16
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-13.8-6.84-36.1-53.5
Capital Expenditures-2.87-3.29-5.09-7.36
Purchase of Fixed Assets
Other Investing Cash Flow Items-10100-6.72
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-12.96.73-5.09-14.1
Financing Cash Flow Items-1.23-4.42137-2.35
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities28.65.4913728.7
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.895.3795.9-38.8

Or unlock with your email

Or unlock with your email